LUXEMBOURG / SAN FRANCISCO – LUXEMBOURG / SAN FRANCISCO – 7th February 2020 – – Inceptua, a global pharmaceutical company and service partner and Portola - US developer and manufacturer…
Inceptua GroupFebruary 7, 2020
NEWTOWN, PA., and LUXEMBOURG, Dec 6, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a Phase 3-stage biopharmaceutical company discovering and developing novel products to treat cancer, with…
Inceptua GroupDecember 6, 2019
To further strengthen its position as a leading pharmaceutical company and service partner, Inceptua appoints Paul Wituschek as President North America effective 1 January, 2020. Paul will take on the…
Inceptua GroupDecember 5, 2019
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
BERLIN / MUNICH – 25 November 2019 – The global pharmaceutical company and service partner Inceptua Group (previously Multipharma GmbH) and Bendalis GmbH – German manufacturer of generic oncology drugs…
Inceptua GroupNovember 25, 2019
LUXEMBOURG – 11 December 2019 – Inceptua announced today that Stefan Fraenkel has been appointed CEO effective 1 January 2020. Alan Raffensperger is appointed Executive Vice-Chairman of the Inceptua Group.…
Inceptua GroupNovember 11, 2019
“Clive joining the team to focus on patient access strengthens our commercialization capabilities, offering even greater support to our partner companies as they try to reach patients in need,” says…
Inceptua GroupNovember 9, 2018
LUXEMBOURG – 10 October 2018 Inceptua Group today announces that Maria Eklind-Cervenka joins as new Chief Medical Officer (CMO). “With Maria joining we are increasing our Medical Leadership, continuing to…
Inceptua GroupOctober 10, 2018
Key appointments strengthen full lifecycle support for pharma LUXEMBOURG – 5 September 2018 – Inceptua Group (previously Multipharma) today announces the strengthening of its Commercial, Strategy, and Supply Chain teams…
Inceptua GroupSeptember 5, 2018
LUXEMBOURG – 23 APRIL 2018 – Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of…
Inceptua GroupApril 23, 2018